• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

AADA board approves pathology position statement

The American Academy of Dermatology Association’s board of directors has unanimously approved a position statement on anatomic pathology billing.

 

The American Academy of Dermatology Association’s board of directors has unanimously approved a position statement on anatomic pathology billing.

The AADA’s position statement affirms the right to bill for one’s own work; affirms the principle of freedom of choice of dermatopathology consultants; supports the value of dermatology office labs; and expresses concern about ethical and legal propriety of several practices that place maximizing revenue over patient welfare.

“This statement establishes a strong position on the wide variety of pathology arrangements that exist today,” Daniel M. Siegel, M.D., former AADA president said in a statement. “Members can use this guidance to ensure that they are practicing in the most appropriate way.”

Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.